Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP

Developmental Biology

Volumn 367, Issue 2, 2012, Pages 187-196

  Straßburger, Katrin ^a   Tiebe, Marcel ^a   Pinna, Federico ^b   Breuhahn, Kai ^b   Teleman, Aurelio A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cell proliferation; Drosophila; HCC; Hippo; Insulin; Yorkie

Indexed keywords

CARRIER PROTEIN; HIPPO PROTEIN; INSULIN; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; REGULATOR PROTEIN; SOMATOMEDIN; TOR COMPLEX 1 PROTEIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; YORKIE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DROSOPHILA; GENE EXPRESSION; GENE TARGETING; IN VIVO STUDY; LIVER CELL CARCINOMA; MAMMAL CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE GROWTH; TRANSCRIPTION INITIATION; UPREGULATION;

MAMMALIA;

EID: 84862146104     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2012.05.008     Document Type: Article

References (74)

1. Basu S., Totty N.F., Irwin M.S., Sudol M., Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell. 2003, 11:11-23.
2. Baumgartner R., Poernbacher I., Buser N., Hafen E., Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev. Cell 2010, 18:309-316.
3. Bennett F.C., Harvey K.F. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr. Biol. 2006, 16:2101-2110.
4. Bhaskar P.T., Hay N. The two TORCs and Akt. Dev. Cell. 2007, 12:487-502.
5. Bjornsti M.A., Houghton P.J. The TOR pathway: a target for cancer therapy. Nat. Rev. Cancer 2004, 4:335-348.
6. Boedigheimer M., Laughon A. Expanded: a gene involved in the control of cell proliferation in imaginal discs. Development 1993, 118:1291-1301.
7. Bohni R., Riesgo-Escovar J., Oldham S., Brogiolo W., Stocker H., Andruss B.F., Beckingham K., Hafen E. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 1999, 97:865-875.
8. Brogiolo W., Stocker H., Ikeya T., Rintelen F., Fernandez R., Hafen E. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr. Biol. 2001, 11:213-221.
9. Cho E., Feng Y., Rauskolb C., Maitra S., Fehon R., Irvine K.D. Delineation of a Fat tumor suppressor pathway. Nat. Genet. 2006, 38:1142-1150.
10. Dai D.L., Martinka M., Li G. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J. Clin. Oncol. 2005, 23:1473-1482.
11. Das Thakur M., Feng Y., Jagannathan R., Seppa M.J., Skeath J.B., Longmore G.D. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr. Biol. 2010, 20:657-662.
12. David O., Jett J., LeBeau H., Dy G., Hughes J., Friedman M., Brody A.R. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res. 2004, 10:6865-6871.
13. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
14. Dowling R.J., Topisirovic I., Alain T., Bidinosti M., Fonseca B.D., Petroulakis E., Wang X., Larsson O., Selvaraj A., Liu Y., Kozma S.C., Thomas G., Sonenberg N. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2010, 328:1172-1176.
15. Edgar B.A. How flies get their size: genetics meets physiology. Nat. Rev. Genet. 2006, 7:907-916.
16. Feng Y., Irvine K.D. Fat and expanded act in parallel to regulate growth through warts. Proc. Natl. Acad. Sci. USA 2007, 104:20362-20367.
17. Ferrigno O., Lallemand F., Verrecchia F., L'Hoste S., Camonis J., Atfi A., Mauviel A. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene 2002, 21:4879-4884.
18. Genevet A., Wehr M.C., Brain R., Thompson B.J., Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev. Cell. 2010, 18:300-308.
19. Glatter T., Schittenhelm R.B., Rinner O., Roguska K., Wepf A., Junger M.A., Kohler K., Jevtov I., Choi H., Schmidt A., Nesvizhskii A.I., Stocker H., Hafen E., Aebersold R., Gstaiger M. Modularity and hormone sensitivity of the Drosophila melanogaster insulin receptor/target of rapamycin interaction proteome. Mol. Syst. Biol. 2011, 7:547.
20. Goberdhan D.C., Paricio N., Goodman E.C., Mlodzik M., Wilson C. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. 1999, 13:3244-3258.
21. Goberdhan D.C., Wilson C. The functions of insulin signaling: size isn't everything, even in Drosophila. Differentiation 2003, 71:375-397.
22. Grzeschik N.A., Parsons L.M., Allott M.L., Harvey K.F., Richardson H.E. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr. Biol. 2010, 20:573-581.
23. Guertin D.A., Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 2007, 12:9-22.
24. Hahn K., Miranda M., Francis V.A., Vendrell J., Zorzano A., Teleman A.A. PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation. Cell Metab. 2010, 11:438-444.
25. Halder G., Johnson R.L. Hippo signaling: growth control and beyond. Development 2011, 138:9-22.
26. Hamaratoglu F., Willecke M., Kango-Singh M., Nolo R., Hyun E., Tao C., Jafar-Nejad H., Halder G. The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat. Cell Biol. 2006, 8:27-36.
27. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004, 18:1926-1945.
28. Heallen T., Zhang M., Wang J., Bonilla-Claudio M., Klysik E., Johnson R.L., Martin J.F. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-461.
29. Huang J., Wu S., Barrera J., Matthews K., Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005, 122:421-434.
30. Justice R.W., Zilian O., Woods D.F., Noll M., Bryant P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995, 9:534-546.
31. Katayama K., Fujita N., Tsuruo T. Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition. Mol. Cell Biol. 2005, 25:5725-5737.
32. Kim S.E., Cho J.Y., Kim K.S., Lee S.J., Lee K.H., Choi K.Y. Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells. Cell Signal. 2004, 16:1309-1317.
33. Kockel L., Kerr K.S., Melnick M., Bruckner K., Hebrok M., Perrimon N. Dynamic switch of negative feedback regulation in Drosophila Akt-TOR signaling. PLoS Genet. 2010, 6:e1000990.
34. Leevers S.J., Weinkove D., MacDougall L.K., Hafen E., Waterfield M.D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 1996, 15:6584-6594.
35. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., Lee J.H., Ciarallo S., Catzavelos C., Beniston R., Franssen E., Slingerland J.M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 2002, 8:1153-1160.
36. Ling C., Zheng Y., Yin F., Yu J., Huang J., Hong Y., Wu S., Pan D. The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc. Natl. Acad. Sci. U S A 2010, 107:10532-10537.
37. Markstein M., Markstein P., Markstein V., Levine M.S. Genome-wide analysis of clustered Dorsal binding sites identifies putative target genes in the Drosophila embryo. Proc. Natl. Acad. Sci. USA 2002, 99:763-768.
38. Medema R.H., Kops G.J., Bos J.L., Burgering B.M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000, 404:782-787.
39. Mirth C.K., Riddiford L.M. Size assessment and growth control: how adult size is determined in insects. Bioessays 2007, 29:344-355.
40. Montagne J., Stewart M.J., Stocker H., Hafen E., Kozma S.C., Thomas G. Drosophila S6 kinase: a regulator of cell size. Science 1999, 285:2126-2129.
41. Nakae J., Kido Y., Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 2001, 22:818-835.
42. Okumura E., Fukuhara T., Yoshida H., Hanada Si, S., Kozutsumi R., Mori M., Tachibana K., Kishimoto T. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat. Cell Biol. 2002, 4:111-116.
43. Pallares-Cartes C., Cakan-Akdogan G., Teleman A.A. Tissue-Specific Coupling between Insulin/IGF and TORC1 Signaling via PRAS40 in Drosophila. Dev. Cell. 2012, 22:172-182.
44. Pan D. Hippo signaling in organ size control. Genes Dev. 2007, 21:886-897.
45. Pan D. The hippo signaling pathway in development and cancer. Dev. Cell 2010, 19:491-505.
46. Pellock B.J., Buff E., White K., Hariharan I.K. The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling. Dev. Biol. 2007, 304:102-115.
47. Perez-Tenorio G., Stal O. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br. J. Cancer 2002, 86:540-545.
48. Radimerski T., Montagne J., Rintelen F., Stocker H., van der Kaay J., Downes C.P., Hafen E., Thomas G. dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat. Cell Biol. 2002, 4:251-255.
49. Reddy B.V., Irvine K.D. The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation. Development 2008, 135:2827-2838.
50. Rossig L., Jadidi A.S., Urbich C., Badorff C., Zeiher A.M., Dimmeler S. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell Biol. 2001, 21:5644-5657.
51. Rulifson E.J., Kim S.K., Nusse R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 2002, 296:1118-1120.
52. Scott M.T., Ingram A., Ball K.L. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J. 2002, 21:6771-6780.
53. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., Arteaga C.L. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 2002, 8:1145-1152.
54. Silva E., Tsatskis Y., Gardano L., Tapon N., McNeill H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr. Biol. 2006, 16:2081-2089.
55. Singer S., Ehemann V., Brauckhoff A., Keith M., Vreden S., Schirmacher P., Breuhahn K. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 2007, 46:759-768.
56. Teleman A.A., Chen Y.W., Cohen S.M. 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev. 2005, 19:1844-1848.
57. Thompson B.J., Cohen S.M. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 2006, 126:767-774.
58. Tyler D.M., Baker N.E. Expanded and fat regulate growth and differentiation in the Drosophila eye through multiple signaling pathways. Dev. Biol. 2007, 305:187-201.
59. Udan R.S., Kango-Singh M., Nolo R., Tao C., Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat. Cell Biol. 2003, 5:914-920.
60. Viglietto G., Motti M.L., Bruni P., Melillo R.M., D'Alessio A., Califano D., Vinci F., Chiappetta G., Tsichlis P., Bellacosa A., Fusco A., Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 2002, 8:1136-1144.
61. Weinkove D., Neufeld T.P., Twardzik T., Waterfield M.D., Leevers S.J. Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor. Curr. Biol. 1999, 9:1019-1029.
62. White M.F. Insulin signaling in health and disease. Science 2003, 302:1710-1711.
63. Willecke M., Hamaratoglu F., Kango-Singh M., Udan R., Chen C.L., Tao C., Zhang X., Halder G. The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr. Biol. 2006, 16:2090-2100.
64. Wirtz-Peitz F., Nishimura T., Knoblich J.A. Linking cell cycle to asymmetric division: Aurora-A phosphorylates the Par complex to regulate Numb localization. Cell 2008, 135:161-173.
65. Wu Q., Brown M.R. Signaling and function of insulin-like peptides in insects. Annu. Rev. Entomol. 2006, 51:1-24.
66. Wu S., Liu Y., Zheng Y., Dong J., Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell. 2008, 14:388-398.
67. Xin M., Kim Y., Sutherland L.B., Qi X., McAnally J., Schwartz R.J., Richardson J.A., Bassel-Duby R., Olson E.N. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal 2011, 4. ra70.
68. Yu J., Zheng Y., Dong J., Klusza S., Deng W.M., Pan D. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev. Cell. 2010, 18:288-299.
69. Yuan Z., Kim D., Shu S., Wu J., Guo J., Xiao L., Kaneko S., Coppola D., Cheng J.Q. Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. J. Biol. Chem. 2010, 285:3815-3824.
70. Zhang J., Ji J.Y., Yu M., Overholtzer M., Smolen G.A., Wang R., Brugge J.S., Dyson N.J., Haber D.A. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat. Cell Biol. 2009, 11:1444-1450.
71. Zhao B., Li L., Guan K.L. Hippo signaling at a glance. J. Cell Sci. 2010, 123:4001-4006.
72. Zhao B., Li L., Lei Q., Guan K.L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010, 24:862-874.
73. Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J., Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G., Lai Z.C., Guan K.L. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007, 21:2747-2761.
74. Zheng T., Wang J., Jiang H., Liu L. Hippo signaling in oval cells and hepatocarcinogenesis. Cancer. Lett. 2011, 302:91-99.